Published in Am J Obstet Gynecol on November 01, 1989
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ (2007) 6.73
Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest (1997) 3.76
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39
Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol (2002) 2.99
Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation (2011) 2.55
Molecular mechanisms of preeclampsia. Microvasc Res (2007) 1.90
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension. Hypertension (2009) 1.82
Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension (2008) 1.72
Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J (2006) 1.65
Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol (1999) 1.65
Angiogenic factors and preeclampsia. Semin Nephrol (2011) 1.58
Hypertension and maternal-fetal conflict during placental malaria. PLoS Med (2006) 1.56
Magnesium sulfate for the treatment of eclampsia: a brief review. Stroke (2009) 1.52
Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol (2009) 1.52
Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension (2009) 1.49
Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens (Greenwich) (2013) 1.48
Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology (2008) 1.47
Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension (2008) 1.45
Potential markers of preeclampsia--a review. Reprod Biol Endocrinol (2009) 1.44
Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens (2009) 1.41
Uric acid as a pathogenic factor in preeclampsia. Placenta (2008) 1.38
Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol (2007) 1.37
Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension (2011) 1.34
Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol (2007) 1.33
A brief overview of preeclampsia. J Clin Med Res (2013) 1.23
The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol (2004) 1.22
Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol (1985) (2010) 1.21
Susceptibility loci for preeclampsia on chromosomes 2p25 and 9p13 in Finnish families. Am J Hum Genet (2002) 1.21
How disturbed sleep may be a risk factor for adverse pregnancy outcomes. Obstet Gynecol Surv (2009) 1.20
The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta (2008) 1.19
A comprehensive review of hypertension in pregnancy. J Pregnancy (2012) 1.16
Thrombophilia and pregnancy. Reprod Biol Endocrinol (2003) 1.16
Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling. Arterioscler Thromb Vasc Biol (2009) 1.14
Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro. Mol Endocrinol (2009) 1.11
If we know so much about preeclampsia, why haven't we cured the disease? J Reprod Immunol (2013) 1.10
Is inflammation the cause of pre-eclampsia? Biochem Soc Trans (2011) 1.09
Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med (2011) 1.07
Preeclampsia--an endothelial cell disorder plus "something else"? Am J Obstet Gynecol (1990) 1.07
Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med (2008) 1.07
Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PLoS One (2012) 1.05
Epistasis between COMT and MTHFR in maternal-fetal dyads increases risk for preeclampsia. PLoS One (2011) 1.04
Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol (2011) 1.04
Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ (2012) 1.02
Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study. BMC Med Genet (2011) 1.01
Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med (2011) 1.01
Magnesium in disease. Clin Kidney J (2012) 1.00
Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol (2014) 1.00
Uric acid induces trophoblast IL-1β production via the inflammasome: implications for the pathogenesis of preeclampsia. Am J Reprod Immunol (2011) 1.00
Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol (2010) 1.00
Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med (2012) 0.99
CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia? J Matern Fetal Neonatal Med (2007) 0.99
Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair (2010) 0.99
Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest (1997) 0.97
Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia. J Reprod Immunol (2014) 0.96
Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch (2008) 0.96
Renin angiotensin signaling in normal pregnancy and preeclampsia. Semin Nephrol (2011) 0.95
Human placental microRNAs and preeclampsia. Biol Reprod (2013) 0.94
Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial. Br J Nutr (2014) 0.94
Maternal serum adiponectin multimers in preeclampsia. J Perinat Med (2009) 0.92
Exposure to experimental preeclampsia in mice enhances the vascular response to future injury. Hypertension (2015) 0.92
Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy (2011) 0.92
Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods. J Perinat Med (2010) 0.92
Elevated plasma chymotrypsin-like protease (chymase) activity in women with preeclampsia. Hypertens Pregnancy (2010) 0.92
Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci (2008) 0.91
Pregnant serum induces neuroinflammation and seizure activity via TNFα. Exp Neurol (2012) 0.91
Severe preeclampsia is characterized by increased placental expression of galectin-1. J Matern Fetal Neonatal Med (2008) 0.91
A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs (2010) 0.91
Heme Oxygenase-1 Attenuates Hypoxia-Induced sFlt-1 and Oxidative Stress in Placental Villi through Its Metabolic Products CO and Bilirubin. Int J Hypertens (2011) 0.91
Oxidative stress in preeclampsia and the role of free fetal hemoglobin. Front Physiol (2015) 0.91
Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta (2010) 0.91
Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol (2012) 0.90
Elucidating immune mechanisms causing hypertension during pregnancy. Physiology (Bethesda) (2013) 0.89
Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin Exp Immunol (2004) 0.89
Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm? Br J Pharmacol (2015) 0.89
Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products. J Matern Fetal Neonatal Med (2010) 0.88
Study of plasma adrenomedullin level in normal pregnancy and preclampsia. Medscape J Med (2008) 0.87
Retinol binding protein 4--a novel association with early-onset preeclampsia. J Perinat Med (2010) 0.87
The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res (2012) 0.86
Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies. J Matern Fetal Neonatal Med (2007) 0.86
Elevated maternal IL-16 levels, enhanced IL-16 expressions in endothelium and leukocytes, and increased IL-16 production by placental trophoblasts in women with preeclampsia. J Immunol (2008) 0.86
Role of reactive oxygen species during hypertension in response to chronic antiangiogenic factor (sFlt-1) excess in pregnant rats. Am J Hypertens (2010) 0.86
Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia. Am J Pathol (2007) 0.86
Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming. Front Pharmacol (2014) 0.86
Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model. PLoS One (2014) 0.86
Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci (2015) 0.85
Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection. Br J Clin Pharmacol (2006) 0.85
Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. Am J Reprod Immunol (2010) 0.85
The responsiveness of isolated human hand vein endothelial cells in normal pregnancy and in pre-eclampsia. J Physiol (1998) 0.85
ST2 and IL-33 in pregnancy and pre-eclampsia. PLoS One (2011) 0.85
Pentraxin 3 in amniotic fluid: a novel association with intra-amniotic infection and inflammation. J Perinat Med (2010) 0.84
Placental implications of peroxisome proliferator-activated receptors in gestation and parturition. PPAR Res (2008) 0.84
Genetic dissection of the pre-eclampsia susceptibility locus on chromosome 2q22 reveals shared novel risk factors for cardiovascular disease. Mol Hum Reprod (2013) 0.84
A follow-up linkage study of Finnish pre-eclampsia families identifies a new fetal susceptibility locus on chromosome 18. Eur J Hum Genet (2013) 0.84
Evolutionary origins of the placental expression of chromosome 19 cluster galectins and their complex dysregulation in preeclampsia. Placenta (2014) 0.84
Plasma granulysin concentrations and preeclampsia risk. Clin Biochem (2006) 0.83
The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth (2006) 0.83
Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas. Placenta (2006) 0.83
Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia. J Matern Fetal Neonatal Med (2010) 0.83
The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia. Angiogenesis (2012) 0.82
Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell (1991) 4.31
Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology (2003) 2.80
The two stage model of preeclampsia: variations on the theme. Placenta (2008) 2.78
Global gene profiling in human endometrium during the window of implantation. Endocrinology (2002) 2.48
Immunobiology of endometriosis. Fertil Steril (2001) 2.29
Elevated levels of S-nitrosoalbumin in preeclampsia plasma. Circ Res (2001) 2.21
Incidence of persistent birth injury in macrosomic infants: association with mode of delivery. Am J Obstet Gynecol (1997) 2.20
Prothrombin is activated on vascular endothelial cells by factor Xa and calcium. Proc Natl Acad Sci U S A (1983) 2.06
Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood (2000) 1.93
Evaluation of tests for infectious mononucleosis through proficiency testing. Health Lab Sci (1976) 1.88
Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens (1991) 1.86
Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol (1988) 1.83
Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol (1989) 1.82
Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet (1999) 1.80
Reduction of variation in results of rheumatoid factor tests by use of a serum reference preparation. J Clin Microbiol (1977) 1.76
Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A (2000) 1.72
Factor V Leiden: death and DNA. Am J Clin Pathol (1999) 1.70
CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing. Public Health Rep (1990) 1.66
Center for disease control diagnostic immunology proficiency testing program results for 1976. J Clin Microbiol (1977) 1.64
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab (1996) 1.64
Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood (1983) 1.63
FGF signalling in the early specification of mesoderm in Xenopus. Development (1993) 1.63
Contribution of vasomotion to vascular resistance: a comparison of arteries from virgin and pregnant rats. J Appl Physiol (1985) (1998) 1.60
Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood (1988) 1.60
Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab (1994) 1.57
First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone. Prenat Diagn (1991) 1.56
Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. J Infect Dis (2000) 1.51
Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol (2000) 1.48
Which plasma factors bring about disturbance of endothelial function in pre-eclampsia? Lancet (1994) 1.48
Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest (1984) 1.46
Reference preparation to standardize results of serological tests for rheumatoid factor. J Clin Microbiol (1978) 1.44
Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab (2003) 1.42
Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody. Arch Pathol Lab Med (1992) 1.42
The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod (2012) 1.41
Utilization of testing for activated protein C resistance in a reference laboratory. Am J Clin Pathol (1996) 1.40
Lack of response to commercial factor VIII concentrate in hemophilia A. Am J Hematol (1991) 1.39
Separation of the pubic symphysis. An underrecognized peripartum complication. J Reprod Med (1986) 1.39
Anaphylactoid reactions to vascular graft material presenting with vasodilation and subsequent disseminated intravascular coagulation. Anesthesiology (1989) 1.39
Activated protein C resistance and inherited thrombosis. Am J Clin Pathol (1995) 1.38
Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein. Proc Natl Acad Sci U S A (2000) 1.36
Center for Disease Control Diagnostic Immunology Proficiency Testing Program results for 1977. J Clin Microbiol (1978) 1.35
The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta (2010) 1.32
Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience (2010) 1.31
Fast MR imaging of fetal CNS anomalies in utero. AJNR Am J Neuroradiol (2000) 1.28
Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol (1996) 1.27
Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med (1997) 1.27
Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations. Am J Hematol (1988) 1.26
Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab (1996) 1.24
Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol (1996) 1.23
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest (1986) 1.22
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience (2011) 1.16
Center for Disease Control Diagnostic Immunology Proficiency Testing Program results for 1978. J Clin Microbiol (1979) 1.16
Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol (1992) 1.16
Measurement of variation and significance in serologic tests. Ann N Y Acad Sci (1983) 1.13
Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab (1997) 1.12
Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol (2012) 1.11
Relationships between maternal plasma leptin, placental leptin mRNA and protein in normal pregnancy, pre-eclampsia and intrauterine growth restriction without pre-eclampsia. Mol Hum Reprod (2006) 1.09
Results of the Center for Disease Control Proficiency Testing Program for the detection of hepatitis B surface antigen. J Clin Microbiol (1976) 1.08
Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod (1999) 1.08
Mites in the environment of cases of Norwegian scabies. Br J Dermatol (1975) 1.08
Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta (2008) 1.07
Acute myocardial infarction associated with amphetamine use. Mayo Clin Proc (2001) 1.07
Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res (1993) 1.07
Reporting the results of human immunodeficiency virus testing. JAMA (1990) 1.06
To IRB or not to IRB? That is no longer the question. Am J Clin Pathol (2001) 1.06
Comparison of kinetic and end-point diffusion methods for quantitating human serum immunoglobulins. J Clin Microbiol (1978) 1.06
Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol Regul Integr Comp Physiol (2001) 1.05
Interleukin-8 concentrations are elevated in peritoneal fluid of women with endometriosis. Fertil Steril (1995) 1.04
Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol (1998) 1.03
Effect of influenza virus infection on phagocytic and cytopeptic capacities of guinea pig macrophages. Immunol Commun (1974) 1.01
Pathophysiology of preeclampsia. Clin Perinatol (1991) 1.01
Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis. Am J Obstet Gynecol (1993) 1.00
Characteristics of vascular smooth muscle in the maternal resistance circulation during pregnancy in the rat. Am J Obstet Gynecol (1993) 0.99
Temporal regulation of the Xenopus FGF receptor in development: a translation inhibitory element in the 3' untranslated region. Development (1995) 0.99
Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res (1982) 0.99
Placental system A amino acid transport is reduced in pregnancies with small for gestational age (SGA) infants but not in preeclampsia with SGA infants. Placenta (2008) 0.98
Results of a nationwide proficiency test for carcinoembryonic antigen. J Clin Microbiol (1977) 0.98
Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb (1993) 0.97
Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta (2008) 0.96
Endometriosis and infertility: new concepts. Obstet Gynecol Surv (1997) 0.96
Chorioamnionitis--a complex pathophysiologic syndrome. Placenta (2009) 0.96
Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. Placenta (2011) 0.95
Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod (2001) 0.94
The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood (1984) 0.94
Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab (2000) 0.94
Uteroplacental insufficiency lowers the threshold towards hypoxia-induced cerebral apoptosis in growth-retarded fetal rats. Brain Res (2001) 0.94
Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril (2000) 0.93
New insights into the etiology of pre-eclampsia. Ann Med (1993) 0.93
Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod (2000) 0.92
FGF is a prospective competence factor for early activin-type signals in Xenopus mesoderm induction. Development (1995) 0.92
Assessment of laboratory improvement by the Center for Disease Control Diagnostic Immunology Proficiency Testing Program. J Clin Microbiol (1981) 0.92
Developmental gonadal expression of the transcription factor SET and its target gene, P450c17 (17alpha-hydroxylase/c17,20 lyase). DNA Cell Biol (2001) 0.92
Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. J Clin Endocrinol Metab (1998) 0.92